Page last updated: 2024-09-03

reboxetine and Bipolar Disorder

reboxetine has been researched along with Bipolar Disorder in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (66.67)	29.6817
2010's	2 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arumugham, SS; Bond, DJ; Dhanoa, T; Ding, YS; Lam, RW; Puyat, JH; Sossi, V; Vafai, N; Yatham, LN	1
Bürgy, M	1
Arnone, D; Hansen, L; Kerr, JS	1
Camarasa, X; Duboc, A; Khazaal, Y; Lopez-Martinez, E; Zullino, DF	1
Easterbrook, G; Kupa, A; Lu, TY; Mangoni, AA	1
Benabarre, A; Colom, F; Corbella, B; Gastó, C; Martínez-Arán, A; Reinares, M; Vieta, E	1

Trials

1 trial(s) available for reboxetine and Bipolar Disorder

Article	Year
Escitalopram/reboxetine combination in depressed patients with substance use disorder. Progress in neuro-psychopharmacology & biological psychiatry, 2005, Volume: 29, Issue:1 Topics: Adult; Alcoholism; Antidepressive Agents; Bipolar Disorder; Citalopram; Depressive Disorder, Major; Diagnosis, Dual (Psychiatry); Drug Combinations; Female; Humans; Morpholines; Psychiatric Status Rating Scales; Reboxetine; Substance-Related Disorders	2005

Article

Year

Escitalopram/reboxetine combination in depressed patients with substance use disorder.

Progress in neuro-psychopharmacology & biological psychiatry, 2005, Volume: 29, Issue:1

Topics: Adult; Alcoholism; Antidepressive Agents; Bipolar Disorder; Citalopram; Depressive Disorder, Major; Diagnosis, Dual (Psychiatry); Drug Combinations; Female; Humans; Morpholines; Psychiatric Status Rating Scales; Reboxetine; Substance-Related Disorders

2005

Other Studies

5 other study(ies) available for reboxetine and Bipolar Disorder

Article	Year
A Positron Emission Tomography Study of Norepinephrine Transporter Occupancy and Its Correlation with Symptom Response in Depressed Patients Treated with Quetiapine XR. The international journal of neuropsychopharmacology, 2018, 02-01, Volume: 21, Issue:2 Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Bipolar Disorder; Delayed-Action Preparations; Depressive Disorder, Major; Dibenzothiazepines; Female; Humans; Hypothalamus; Locus Coeruleus; Male; Middle Aged; Norepinephrine Plasma Membrane Transport Proteins; Positron-Emission Tomography; Quetiapine Fumarate; Reboxetine; Young Adult	2018
Successful treatment of ultradian or ultra-ultra-rapid cycling: a case report. Journal of affective disorders, 2011, Volume: 133, Issue:3 Topics: Affect; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Dibenzothiazepines; Female; Humans; Lamotrigine; Morpholines; Quetiapine Fumarate; Reboxetine; Treatment Outcome; Triazines; Young Adult	2011
Acute dystonic reaction in an elderly patient with mood disorder after titration of paroxetine: possible mechanisms and implications for clinical care. Journal of psychopharmacology (Oxford, England), 2002, Volume: 16, Issue:4 Topics: Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dystonic Disorders; Electroconvulsive Therapy; Humans; Male; Morpholines; Olanzapine; Paroxetine; Pirenzepine; Reboxetine	2002
Profound weight loss associated with reboxetine use in a 44-year-old woman. British journal of clinical pharmacology, 2005, Volume: 60, Issue:2 Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Bipolar Disorder; Body Mass Index; Female; Humans; Morpholines; Reboxetine; Weight Loss	2005
Reboxetine-induced hypomania. The Journal of clinical psychiatry, 2001, Volume: 62, Issue:8 Topics: Adult; Antidepressive Agents; Bipolar Disorder; Female; Humans; Male; Middle Aged; Morpholines; Reboxetine	2001